|
RIF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.235000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.954200E-01 |
| Normal-vs-Stage2 |
7.591600E-01 |
| Normal-vs-Stage3 |
7.465800E-02 |
| Normal-vs-Stage4 |
4.793900E-02 |
| Stage1-vs-Stage2 |
5.163000E-01 |
| Stage1-vs-Stage3 |
1.465750E-02 |
| Stage1-vs-Stage4 |
1.142030E-02 |
| Stage2-vs-Stage3 |
3.677400E-01 |
| Stage2-vs-Stage4 |
2.593000E-01 |
| Stage3-vs-Stage4 |
7.040200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.451800E-01 |
| Normal-vs-AfricanAmerican |
3.039800E-03 |
| Normal-vs-Asian |
3.951600E-01 |
| Caucasian-vs-AfricanAmerican |
1.839700E-03 |
| Caucasian-vs-Asian |
4.215200E-01 |
| AfricanAmerican-vs-Asian |
3.168400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.475750E-01 |
| Normal-vs-Female |
6.876400E-01 |
| Male-vs-Female |
3.786000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.773000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.416400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.853000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.051600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.942400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.854800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.886400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.425200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.981220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.593000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.568800E-01 |
| Normal-vs-Grade 2 |
4.580400E-01 |
| Normal-vs-Grade 3 |
1.493800E-01 |
| Normal-vs-Grade 4 |
1.080360E-02 |
| Grade 1-vs-Grade 2 |
5.539000E-01 |
| Grade 1-vs-Grade 3 |
8.314000E-02 |
| Grade 1-vs-Grade 4 |
2.235900E-02 |
| Grade 2-vs-Grade 3 |
7.416700E-03 |
| Grade 2-vs-Grade 4 |
1.644730E-03 |
| Grade 3-vs-Grade 4 |
1.298050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.333900E-02 |
| Normal-vs-ccB subtype |
3.429700E-02 |
| ccA subtype-vs-ccB subtype |
6.86020000029153E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.930600E-01 |
| Normal-vs-N1 |
8.343600E-01 |
| N0-vs-N1 |
9.845000E-01 |
|
|
